Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
The law reflects growing interest in using existing imaging studies to identify cardiovascular disease risk without requiring additional scans, radiation exposure or costs.
New research could provide useful information for cancer registries and potentially help policymakers better evaluate screening outcomes to develop more effective guidelines.
Former SCCT president Ed Nicol, MD, knows there has been interest in the potential of automated CT exams. However, he isn't so sure they are possible at this point in time for a number of reasons.
Has overuse of mammography created an epidemic of breast cancer pseudo-survivorship? That was the provocative question asked in a recent editorial published by Forbes.
A $2.5 million grant from the National Institutes of Health/National Cancer Institute will be given to the University of Oklahoma (OU) and Mercy Hospital Oklahoma City to go toward the development of new short-term breast cancer risk prediction models.
Who doesn’t like getting things for free? It’s even better when the freebies are used to incentivize patients to quit smoking or eat healthy. But should those gift cards, event tickets and t-shirts be used to get women to come in for a mammogram?
Research has once again shown that false-positive screening mammography results lead to increased anxiety for the women that receive them, and that these feelings can last for months. But how much should we fear the fear itself?
A study published last year in the Lancet showing the merits of treating breast cancer with intraoperative radiation therapy offered hope that the technique could be a safer alternative to traditional treatment. But not everybody is convinced.
CT utilization in children’s hospitals is declining, possibly due to potential side effects related to pediatric exposure to ionizing radiation, according to a new study published in Pediatrics.
Kubtec®, the leader in innovation for digital specimen radiography systems, announces the U.S. Patent & Trademark Office has issued Patent No. 14/503,130 for the technology incorporated into the Mozart® System with TomoSpec® Technology.
A major study this week in JAMA Oncology, which looked at mortality rates following a diagnosis of ductal carcinoma in situ (DCIS), provided some important insights and challenged preconceived notions. It also spurred even more questions.
